Get the app!
Back to Trades

Siegrist Jonathan Philip

EVP of R&D & CTOCIK 0002040321

Total Volume

$1.3M

4 filings

Purchases

$0

0 buy txns

Sales

$0

0 sell txns

Net Activity

$0

net bought

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
4
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Siegrist Jonathan Philip, EVP of R&D & CTO, accounts for 4 disclosed filings worth $1.3M, all concentrated in QuidelOrtho Corp (QDEL), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.

Associated Companies

QuidelOrtho Corp (QDEL)

4 filings

$1.3M

Trading History

4 loaded
Oct 19QDEL
QuidelOrtho Corp
Siegrist Jonathan PhilipEVP of R&D & CTOExercise$93.1K
Feb 3QDEL
QuidelOrtho Corp
Siegrist Jonathan PhilipEVP of R&D & CTOAward$982.2K
Feb 2QDEL
QuidelOrtho Corp
Siegrist Jonathan PhilipEVP of R&D & CTOGrant$27.7K
Oct 17QDEL
QuidelOrtho Corp
Siegrist Jonathan PhilipEVP of R&D & CTOGrant$182.3K

4 filings